Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1334324.RAxayPs6bPWnG_0EM_DLu95MXn9-O_4qIjrlYld1SvChM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1334324.RAxayPs6bPWnG_0EM_DLu95MXn9-O_4qIjrlYld1SvChM130_assertion type Assertion NP1334324.RAxayPs6bPWnG_0EM_DLu95MXn9-O_4qIjrlYld1SvChM130_head.
- NP1334324.RAxayPs6bPWnG_0EM_DLu95MXn9-O_4qIjrlYld1SvChM130_assertion description "[We conclude that among the SRCTs, MIC2 expression is not limited to Ewing's sarcoma and primitive neuroectodermal tumors, but also shows strong and reliable expression in lymphoblastic lymphomas and related leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1334324.RAxayPs6bPWnG_0EM_DLu95MXn9-O_4qIjrlYld1SvChM130_provenance.
- NP1334324.RAxayPs6bPWnG_0EM_DLu95MXn9-O_4qIjrlYld1SvChM130_assertion evidence source_evidence_literature NP1334324.RAxayPs6bPWnG_0EM_DLu95MXn9-O_4qIjrlYld1SvChM130_provenance.
- NP1334324.RAxayPs6bPWnG_0EM_DLu95MXn9-O_4qIjrlYld1SvChM130_assertion SIO_000772 8163272 NP1334324.RAxayPs6bPWnG_0EM_DLu95MXn9-O_4qIjrlYld1SvChM130_provenance.
- NP1334324.RAxayPs6bPWnG_0EM_DLu95MXn9-O_4qIjrlYld1SvChM130_assertion wasDerivedFrom befree-2016 NP1334324.RAxayPs6bPWnG_0EM_DLu95MXn9-O_4qIjrlYld1SvChM130_provenance.
- NP1334324.RAxayPs6bPWnG_0EM_DLu95MXn9-O_4qIjrlYld1SvChM130_assertion wasGeneratedBy ECO_0000203 NP1334324.RAxayPs6bPWnG_0EM_DLu95MXn9-O_4qIjrlYld1SvChM130_provenance.